Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triple Negative Breast Cancer Biomarker Study

NCT01111175 is registered in ClinicalTrials.gov with US Oncology Research as lead sponsor.

NCT NCT01111175
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01111175 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triple Negative Breast Cancer Biomarker Study
Lead sponsor
US Oncology Research
Phase
Observational
Overall status
Completed
Start date
May 31, 2010
Completion date
June 30, 2013
Enrollment
14 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer, triple negative breast cancer